Tumor necrosis factor-α and interleukin 4 in myeloma cell precursor differentiation

Leukemia and Lymphoma

Volumn 21, Issue 1-2, 1996, Pages 31-36

  Sawamura, Morio ^a   Murakami, Hirokazu ^b   Tsuchiya, Jun ^c  

^a National Hospital Organization   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

IL 4; Monoclonal gammopathy of undetermined significance; Myeloma; Precursor cell; TNF

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 4; MELPHALAN; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MONONUCLEAR CELL; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEM CELL;

EID: 0029670783     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609067576     Document Type: Review

References (45)

1. Epstein, J. (1992) Myeloma phenotype: Clues to disease origin and manifestation. Hematol. Oncol. Clin. North. Am., 6, 249-256.
2. Kubagawa, H., Vogler, L. B., Capla, J. D., Conrad, M. E., Lawton, A. R., and Cooper, M. D. (1979) Studies on the clonal origin of multiple myeloma. J. Exp. Med., 150, 792-807.
3. Pettersson, D., Mellstedt, H., and Holm, G. (1980) Monoclonal B lymphocytes in multiple myeloma. Scand. J. Immunol., 12, 375-382.
4. Shimazaki, C., Gotoh, H., Oku, N., Inaba, T., Murakami, S., Oku, N., Itoh, K., Ura, Y., Nakagawa, M., and Fujita, N. (1991) Detection of minimal residual myeloma cells by dual parameter analysis of DNA and cytoplasmic immunoglobulin. Acta Haematol., 85, 20-25.
5. Shimazaki, C., Fried, J., Perez, A. G., Scheinberg, D. A., Atzpodien, J., Wang, C. Y., Wisniewolski, R., and Clarkson, B. D. (1990) Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma. Acta Haematol., 83, 123-129.
6. Caligaris-Cappio, F., Bergui, L., Tesio, L., Pizzolo, G., Malavasi, F., Chilosi, M., Campana, D., Van Camp, B., and Janossy, G. (1985) Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J. Clin. Invest., 76, 1243-1251.
7. Grogan, T. M., Durie, B. G. M., Lomen, C., Spier, C., Wirt, D. P., Nagle, R., Wilson, G. S., Richter, L., Vera, E., Maxey, V., McDaniel, K., and Rangel, C. (1987) Delineation of a novel pre-B cell component in plasma cell myeloma: Immunological, immunophenokinetic, genotypic. cytologic, cell culture, and kinetic features. Blood, 70, 932-942.
8. Epstein, J., Barlogie, B., Katzmann, J., and Alexanian, R. (1988) Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood, 71, 861-865.
9. Berenson, J., Wong, R., Kim, K., Brown, N., and Lichtenstein, A. (1987) Evidence for peripheral blood B lymphocyte but not T-lymphocyte involvement in multiple myeloma. Blood, 70, 1550-1553.
10. Chiu, E. K. W., Gasneshaguru, K., Hoffbrand, A. V., and Mehta, A. B. (1989) Circulating monoclonal B lymphocytes in multiple myeloma. Br. J. Haemat., 72, 28-31.
11. van Reit, I., Heirman, C., Lacor, P., De Waele, M., Thielemans, K., and van Camp, B. (1989) Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies. Br. J. Haematol., 73, 289-295.
12. Billadeau, D., Quam, L., Thomas, W., Kay, N., Greipp, P., Kyle, R., Oken, M. M., and Van Ness, B. (1992) Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood, 80, 1818-1824.
13. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A., and Kishimoto, T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 332, 83-85.
14. Klein, B., Zhang, X. G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M., and Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
15. Zhang, X. G., Bataille, R., Jourdan, M., Saeland, S., Banchereau, J., Mannoni, P., and Klein, B. (1990) Granulocyte-macrophage colony stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood, 72, 2599-2605.
16. Sawamura, M., Murakami, H., Tamura, J., Matsushima, T., Sato, S., Naruse, T., and Tsuchiya, J. (1994) Tumour necrosis factor-α and interleukin 4 promote the differentiation of myeloma cell precursors in multiple myeloma. Br. J. Haematol., 88, 17-23.
17. Durie, B. G. M. and Salmon, S. E. (1975) A clinical staging system for multiple myeloma. Cancer, 36, 842-854.
18. Lichtenstein, A., Berenson, J., Norman, D., Chang, M. P., and Carlile, A. (1989) Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood, 74, 1266-73.
19. Carter, A., Merchav, S., Silvian-Draxler, J., and Tatarsky, I. (1990) The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma. Br. J. Haematol., 74, 424-431.
20. Hata, H., Matsuzaki, H., and Takatsuki, K. (1990) Autocrine growth by two cytokines, interleukin-6 and tumor necrosis factor alpha, in the myeloma cell line KHM-1A. Acta Haemat., 83, 133-136.
21. Sonneveld, P., Schoester, M., and de Leeuw, K. (1991) In vitro Ig-synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors. Br. J. Haematol., 79, 589-594.
22. Tanabe, O., Kawano, M., Tanaka, H., Iwato, K., Asaoku, H., Ishikawa, H., Nobuyoshi, M., Hirano, T., Kishimoto, T., and Kuramoto, A. (1989) BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells. Am. J. Hematol., 31, 258-262.
23. Herrmann, F., Andreeff, M., Gruss, H. J.. Brach, M. A., Lubbert, M., and Mertelsmann, R. (1991) Interleukin-4 inhibits growth of multiple myeloma by suppressing interleukin-6 expression. Blood, 78, 2070-2074.
24. Taylor, C. W., Grogan, T. M., and Salmon, S. E. (1990) Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms. Blood, 75, 1114-1118.
25. Famularo, G., Giacomelli, R., Di Giovanni, S., Sacchetti, S., and Tonietti, G. (1991) Cytokine production in patients with monoclonal gammopathies. J. Clini. Lab. Immunol., 34, 63-69.
26. Barlogie, B., Epstein, J., Selvanayagam, P., and Alexanian, R. (1989) Plasma cell myeloma. New biological insights and advances in therapy. Blood, 73, 865-879.
27. Caligaris-Cappio, F., Gregoretti, M. G., Ghia, P., and Bergui, L. (1992) In vitro growth of human multiple myeloma: Implications for biology and therapy. Hematol. Oncol. Clin. North. Am., 6, 257-271.
28. Bergui, L., Schena, M., Gaidano, G, Riva, M., and Caligalis-Cappio, F. (1989) Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J. Exp. Med., 170, 613-618.
29. Tokumine, Y., Nishimori, Y., Shibayama, H., Shibano, M., Tagawa, S., Machii, T., and Kitani, T. (1993) Failure of IL-3 plus IL-6 to induce the proliferation and differentiation of malignant plasma cell precursors from peripheral blood in multiple myeloma. Leukemia, 7, 333-335.
30. Goto, H., Shimazaki, C., Ashihara, E., Ohkawa, K., Oku, N., Inaba, T., Murakami, S., Fujita, N., and Nakagawa, M. (1992) Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significance. Acta Haematol., 88, 129-135.
31. Klein, B., Zhang, X. G., Lu, Z. Y., and Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863-872.
32. Stewart, A. K. and Schwartz, R. S. (1994) Immunoglobulin V regions and the B cell. Blood, 83, 1717-1730.
33. Witzig, T., Gonchoroff, N., Katzmann, J., Therneau, T., Kyle, R., and Greipp, P. (1988) Peripheral blood labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J. Clin. Oncol., 6, 1041-1046.
34. Witzig, T. E., Gonchoroff, N. J., Ahmann, G. A., Katzmann, J. A., and Greipp, P. R. (1991) T cell depletion using anti-CD2-coated magnetic beads simplifies the detection of peripheral blood plasma cells. J. Immunol. Methods, 144, 253-256.
35. Witzig, T. E., Kyle, R. A., and Greipp, P. R. (1992) Circulating peripheral blood plasma cells in multiple myeloma. Curr. Top. Microbiol. Immunol., 182, 195-199.
36. + monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood, 78, 711-719.
37. Corradini, P., Boccadoro, M., Voena, C., and Pileri, A. (1993) Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cμ sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas. J. Exp. Med., 178, 1091-1096.
38. Barlogie, B., Alexanian, R., Pershouse, M., Smallwood, L., and Smith, L. (1985) Cytoplasmic immunoglobulin content in multiple myeloma. J. Clin. Invest., 76, 765-769.
39. Potter, M. (1992) Perspectives on the origins of multiple myeloma and plasmacytomas in mice. Hematol. Oncol. Clin. North. Am., 6, 211-223.
40. Epstein, J. H., Xiao, H. Q., and He, X. Y. (1990) Markers of multiple hematopoietic-cell lineages in multiple myeloma. N. Engl. J. Med., 322, 664-668.
41. Billadeau, D., Ahmann, G., Greipp, P., and van Ness, B. (1993) The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J. Exp. Med. 178, 1023-1031.
42. Zhang, X. G., Gaillard, J. P., Robillard, N., Lu, Z. Y., Gu, Z. J., Jourdan, M., Boiron, J. M., Bataille, R., and Klein, B. (1994) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood, 83, 3654-3663.
43. Bakkus, M. H. C., Heirman, C., van Riet, I., van Camp, B., and Thielemans, K. (1992) Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood, 80, 2326-2335.
44. Pilarski, L. M. and Belch, A. R. (1993) Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood, 83, 724-736.
45. Vescio, R. A., Hong, C. H., Cao, J., Kim, A., Schiller, G. J., Lichtenstein, A. K., Berenson, R. J., and Berenson, J. R. (1994) The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood, 84, 3283-3290.